Drug discovery and development
We identify, develop and commercialise promising ideas into successful cancer therapeutics, diagnostics and enabling technologies.
Our partnerships
We can't beat cancer alone. We work closely with partners to progress research and turn more discoveries into effective tools, treatments and diagnostics so that cancer patients benefit from research.
How we partner
We partner in several ways, including through licensing, start-ups, collaborations, and forming drug discovery alliances. Our partners include academic institutions, pharmaceutical and biotechnology companies, investors, and other medical research charities.
Together with our partners, we push the boundaries of science to deliver innovative breakthroughs and address cancer patients' unmet needs.
Pharmaceutical and biotechnology companies
We continuously seek new and innovative partnerships. We have a portfolio of licensing opportunities across therapeutics, data and diagnostics, and offer partnering opportunities with our drug discovery and development teams.
Researchers
We partner with researchers to develop their research to its full potential. We support researchers to translate their work through our funding, capabilities, and expertise, tailored to suit their needs.
Investors
We spot and build unique investment opportunities. We partner with investors to accelerate the development of world-class oncology focused opportunities across therapeutics, diagnostics, medtech and AI sectors.
A snapshot of our partners
Abcam
Astex Pharmaceuticals
AstraZeneca
Experimental Drug Development Centre
iOnctura
Karolinska Institute
Our news
Find out more about partnering with us
We're seeking powerful partnerships with research institutions, commercial organisations, researchers and investors.